10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001493152-24-019917`
Period End Date	20240331
Filing Date	20240515
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 118 Income Statement 68 Cash Flow Statement 112 Stockholders Equity 40

Balance Sheet 118 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.44M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.63M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.63M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.65M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.65M	USD	Point-in-time
Funds receivable from New Jersey net operating loss and Other Receivables	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Funds receivable from New Jersey net operating loss and Other Receivables	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Funds receivable from New Jersey net operating loss and Other Receivables	`AccountsReceivableNetCurrent`	$1.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss and Other Receivables	`AccountsReceivableNetCurrent`	$1.18M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$302.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$302.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$364.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$364.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.31M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.31M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.56M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.56M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$118.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$118.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	50.25M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	50.25M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.10M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.10M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$127.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$127.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$697.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$697.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$763.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$763.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	50.25M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	50.25M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.10M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Total assets	`Assets`	$19.38M	USD	Point-in-time
Total assets	`Assets`	$19.38M	USD	Point-in-time
Total assets	`Assets`	$16.19M	USD	Point-in-time
Total assets	`Assets`	$16.19M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$240.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$240.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$223.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$223.00K	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$1.62M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$1.62M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	-	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.88M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.88M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$537.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$537.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$495.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$495.00K	USD	Point-in-time
Note payable, net	`LongTermNotesPayable`	-	USD	Point-in-time
Note payable, net	`LongTermNotesPayable`	-	USD	Point-in-time
Note payable, net	`LongTermNotesPayable`	$950.00K	USD	Point-in-time
Note payable, net	`LongTermNotesPayable`	$950.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$9.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.36M	USD	Point-in-time
Commitments and contingencies (Notes 9, 10 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 9, 10 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 50,251,933 and 49,102,484 as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$50.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 50,251,933 and 49,102,484 as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$50.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 50,251,933 and 49,102,484 as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 50,251,933 and 49,102,484 as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.41M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.41M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-409.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-409.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-415.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-415.32M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$4.83M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$4.83M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$34.99M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$34.99M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$16.19M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$16.19M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.38M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.38M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.00K	USD	1 Quarter
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.00K	USD	1 Quarter
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$49.00K	USD	1 Quarter
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$49.00K	USD	1 Quarter
Total Revenues	`Revenues`	$40.00K	USD	1 Quarter
Total Revenues	`Revenues`	$40.00K	USD	1 Quarter
Total Revenues	`Revenues`	$49.00K	USD	1 Quarter
Total Revenues	`Revenues`	$49.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	-	USD	1 Quarter
Production costs	`ManufacturingCosts`	-	USD	1 Quarter
Production costs	`ManufacturingCosts`	$8.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$8.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.95M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.95M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.05M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.81M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.81M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.29M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.29M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$5.77M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$5.77M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$4.34M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$4.34M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.29M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.29M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.73M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.73M	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$203.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$203.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-92.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-92.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$81.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$81.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$199.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$199.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	$72.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	$72.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	-	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	-	USD	1 Quarter
(Loss) on sale of assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
(Loss) on sale of assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
(Loss) on sale of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-23.00K	USD	1 Quarter
(Loss) on sale of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-23.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	-	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	-	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-255.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-255.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.66M	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.08	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.08	USD	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	48.40M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	48.40M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	49.46M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	49.46M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	49.46M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	49.46M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.40M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.40M	shares	1 Quarter

Cash Flow Statement 112 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.66M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.66M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$11.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$11.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$9.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$9.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$36.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$36.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$49.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$49.00K	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfFinancingCostsAndDiscounts`	$73.00K	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfFinancingCostsAndDiscounts`	$73.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$-67.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$-67.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$37.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$37.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	-	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	-	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-255.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-255.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$82.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$82.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$203.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$203.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$-92.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$-92.00K	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$180.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$180.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$62.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$62.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$60.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$60.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-23.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-23.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$586.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$586.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$124.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$124.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-540.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-540.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-110.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-110.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.68M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.68M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.82M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.82M	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$598.00K	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$598.00K	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$50.00K	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$50.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$712.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$712.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$158.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$158.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`ProceedsFromPaymentsToAcquireIntangibleAssets`	$-7.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`ProceedsFromPaymentsToAcquireIntangibleAssets`	$-7.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`ProceedsFromPaymentsToAcquireIntangibleAssets`	$50.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`ProceedsFromPaymentsToAcquireIntangibleAssets`	$50.00K	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$29.00K	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$29.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-158.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-158.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$329.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$329.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$100.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$100.00K	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.50M	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.50M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.83M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.83M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$100.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$100.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.66M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.66M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.14M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.14M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.39M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.39M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.39M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.39M	USD	Point-in-time
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$4.00K	USD	1 Quarter
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$4.00K	USD	1 Quarter
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	-	USD	1 Quarter
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	-	USD	1 Quarter

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balance ,value	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$34.99M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$34.99M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$38.47M	USD	Point-in-time
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$100.00K	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$100.00K	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$329.00K	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$329.00K	USD	1 Quarter
Cashless Exercise of Warrants	`ProceedsFromIssuanceOfWarrants`	-	USD	1 Quarter
Cashless Exercise of Warrants	`ProceedsFromIssuanceOfWarrants`	-	USD	1 Quarter
Warrants in shares	`ProceedsFromIssuanceOfWarrantsShares`	3,272.00	shares	1 Quarter
Warrants in shares	`ProceedsFromIssuanceOfWarrantsShares`	3,272.00	shares	1 Quarter
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$82.00K	USD	1 Quarter
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$82.00K	USD	1 Quarter
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$80.00K	USD	1 Quarter
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$80.00K	USD	1 Quarter
Series B preferred shares converted to common	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Series B preferred shares converted to common	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Series B preferred shares converted to common	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Series B preferred shares converted to common	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Committed Shares	`CommittedSharesInValue`	-	USD	1 Quarter
Committed Shares	`CommittedSharesInValue`	-	USD	1 Quarter
Committed Shares (Shares)	`CommittedSharesInShares`	338,600.00	shares	1 Quarter
Committed Shares (Shares)	`CommittedSharesInShares`	338,600.00	shares	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.66M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.66M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.82M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.82M	USD	1 Quarter
Balance ,value	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$34.99M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$34.99M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance ,value	`StockholdersEquity`	$38.47M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.